![](/img/cover-not-exists.png)
Efficacy and tolerability of a new 5HT3-antagonist, DAU 6215 CL, on emesis occurring in the first 24 HRS after cisplatin administration
Del Favero, A., Ciccarese, G., Giglietti, A., Palladino, M.A., Malacarne, P., Indelli, M., Romagnoli, M., Bensi, G., Corti, A.Volume:
29
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/0959-8049(93)91778-J
Date:
January, 1993
File:
PDF, 161 KB
english, 1993